Tag: chemistry
-
Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal
Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies.
-
Process Devised for Continuous Stem Cell Production
Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies.
-
New Drug Shown to Reduce Depressive Behaviors
A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors.
-
Start-Up Formed to Develop Non-Opioid Pain Drugs
A new enterprise is being formed to develop non-addictive drugs for chronic pain that use different biochemical processes than opioid pain relievers.
-
Artificial Beta Cells Shown to Produce Insulin as Needed
A biomedical engineering team developed artificial beta cells that in animal tests perform similar to natural cells in the pancreas to produce insulin as needed for controlling blood glucose levels.
-
Novartis Acquires Nuclear Meds Developer in $3.9B Deal
Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers.
-
Phone-Based Lupus Home Test Kit in Development
A home test kit using smartphone imaging is being created by biomedical engineers to detect kidney inflammation caused by lupus, an autoimmune disorder.
-
Online Game Harnessed to Combat Foodborne Toxins
A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops.
-
Gas-Jet Printing Process Developed for Medications
A team of material scientists and biomedical engineers designed techniques for producing pharmaceuticals on demand by printing drugs as thin films.
-
Drug Delivery Technology Licensed in $2B Deals
The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers.